Potential of thalidomide and thalidomide analogues as immunomodulatory drugs in leprosy and leprosy reactions.
Kaplan
G
G
Laboratory of Cellular Physiology & Immunology, Rockefeller University, New York, New York, USA.
D004893:Erythema Nodosum / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015440:Leprosy, Lepromatous / Q000150:complications / Q000188:drug therapy*; D008297:Male; D011379:Prognosis; D013792:Thalidomide / Q000037:antagonists & inhibitors* / Q000627:therapeutic use*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D013792:Thalidomide